Autophagy regulation and its role in gastric cancer and colorectal cancer

Cancer Biomarkers

Volumn 17, Issue 1, 2016, Pages 1-10

  Zhou, Huangyan ^a,b   Yuan, Min ^a   Yu, Qiongfang ^a   Zhou, Xiaoyan ^a   Min, Weiping ^a,b   Gao, Dian ^a,b  

^a NANCHANG UNIVERSITY   (China)

^b Jiangxi Institute of Medical Science   (China)

Author keywords

Autophagy; colorectal cancer; gastric cancer

Indexed keywords

AUTOPHAGY PROTEIN 5; AUTOPHAGY RELATED PROTEIN 7; BECLIN 1; LIGHT CHAIN 3; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; PEPTIDES AND PROTEINS; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P53; RAS PROTEIN; UNCLASSIFIED DRUG;

AUTOPHAGY; CANCER INHIBITION; CARCINOGENESIS; CELL DEATH; CELL SURVIVAL; CHAPERONE-MEDIATED AUTOPHAGY; COLORECTAL CANCER; HUMAN; MACROAUTOPHAGY; METABOLIC STRESS; MICROAUTOPHAGY; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; STOMACH CANCER; TUMOR GROWTH; ANIMAL; CELL TRANSFORMATION; COLORECTAL NEOPLASMS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

ANIMALS; AUTOPHAGY; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR TARGETED THERAPY; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 84978521852     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-160613     Document Type: Review

References (105)

1. T.P. Ashford, and K.R. Porter, Cytoplasmic components in hepatic cell lysosomes. J Cell Biol 12 (1962), 198-202.
2. A.M. Choi, S.W. Ryter, and B. Levine, Autophagy in human health, and disease. N Engl J Med 368 (2013), 1845-1846.
3. M.A. Jardon, K. Rothe, S. Bortnik, L. Vezenkov, X. Jiang, R.N. Young, J.J. Lum, and S.M. Gorski, Autophagy: From structure to metabolism to therapeutic regulation, Autophagy 9 (2013), 2180-2182.
4. Y. Avalos, J. Canales, R. Bravo-Sagua, A. Criollo, S. Lavandero, and A.F. Quest, Tumor suppression, and promotion by autophagy. Biomed Res Int 2014 (2014), 603980.
5. S. Chen, and J.L. Guan, Tumor-promoting, and -suppressive roles of autophagy in the same mouse model of BrafV600Edriven lung cancer. Cancer Discov 3 (2013), 1225-1227.
6. K. Maiese, Z.Z. Chong, Y.C. Shang, and S. Wang, Targeting disease through novel pathways of apoptosis, and autophagy. Expert Opin Ther Targets 16 (2012), 1203-1214.
7. X. Yang, D.D. Yu, F. Yan, Y.Y. Jing, Z.P. Han, K. Sun, L. Liang, J. Hou, and L.X. Wei, The role of autophagy induced by tumor microenvironment in different cells, and stages of cancer. Cell Biosci 5 (2015), 14.
8. D.C. Rubinsztein, P. Codogno, and B. Levine, Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov 11 (2012), 709-730.
9. N. Mizushima, and M. Komatsu, Autophagy: Renovation of cells, and tissues. Cell 147 (2011), 728-741.
10. Y.S. Kim, J.H. Shin, M.K. Bae, C.Y. Lee, D.J. Kim, K.Y. Chung, and J.G. Lee, Autophagy activity in pulmonary metastatic tumor tissues from colorectal cancer: A pilot study, Yonsei Med J 55 (2014), 1484-1488.
11. E. White, Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 12 (2012), 401-410.
12. L.A. Torre, F. Bray, R.L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal, Global cancer statistics, 2012, CA Cancer J Clin 65 (2015), 87-108.
13. R. Sheng, and Z.H. Qin, The divergent roles of autophagy in ischemia, and preconditioning. Acta Pharmacol Sin 36 (2015), 411-420.
14. E. Wirawan, T. Vanden Berghe, S. Lippens, P. Agostinis, and P. Vandenabeele, Autophagy: For better or for worse. Cell Res 22 (2012), 43-61.
15. K.R. Parzych, and D.J. Klionsky, An overview of autophagy: Morphology, mechanism, and regulation, Antioxid Redox Signal 20 (2014), 460-473.
16. Y. Chen, and D.J. Klionsky, The regulation of autophagy -unanswered questions. J Cell Sci 124 (2011), 161-170.
17. B. Liu, X. Wen, and Y. Cheng, Survival or death: Disequilibrating the oncogenic, and tumor suppressive autophagy in cancer. Cell Death Dis 4 (2013), e892.
18. E.A. Oczypok, T.D. Oury, and C.T. Chu, It?s a cell-eatcell world: Autophagy, and phagocytosis. Am J Pathol 182 (2013), 612-622.
19. Y. Shi, X. He, G. Zhu, H. Tu, Z. Liu, W. Li, S. Han, J. Yin, B. Peng, and W. Liu, Coxsackievirus A16 elicits incomplete autophagy involving the mTOR, and ERK pathways. PLoS ONE 10 (2015), e0122109.
20. E. Yamada, and R. Singh, Mapping autophagy on to your metabolic radar. Diabetes 61 (2012), 272-280.
21. N. Mizushima, T. Yoshimori, and Y. Ohsumi, The role of Atg proteins in autophagosome formation, Annu Rev Cell Dev Biol 27 (2011), 107-132.
22. N. Jaber, Z. Dou, J.S. Chen, J. Catanzaro, Y.P. Jiang, L.M. Ballou, E. Selinger, X. Ouyang, R.Z. Lin, J. Zhang andW.X. Zong, Class III PI3K Vps34 plays an essential role in autophagy, and in heart, and liver function. Proc Natl Acad Sci U S A 109 (2012), 2003-2008.
23. A. Simonsen, and S.A. Tooze, Coordination of membrane events during autophagy by multiple class III PI3-kinase complexes. J Cell Biol 186 (2009), 773-782.
24. D.J. Klionsky, and B.A. Schulman, Dynamic regulation of macroautophagy by distinctive ubiquitin-like proteins. Nat Struct Mol Biol 21 (2014), 336-345.
25. N. Mizushima, A. Kuma, Y. Kobayashi, A. Yamamoto, M. Matsubae, T. Takao, T. Natsume, Y. Ohsumi, and T. Yoshimori, Mouse Apg16L, a novel WD-repeat protein, targets to the autophagic isolation membrane with the Apg12-Apg5 conjugate. J Cell Sci 116 (2003), 1679-1688.
26. V. Pizon, S. Rybina, F. Gerbal, F. Delort, P. Vicart, G. Baldacci, and E. Karsenti, MURF2B, a novel LC3-binding protein, participates with MURF2A in the switch between autophagy, and ubiquitin proteasome system during differentiation of C2C12 muscle cells. PLoS ONE 8 (2013), e76140.
27. H. Nakatogawa, Two ubiquitin-like conjugation systems that mediate membrane formation during autophagy, Essays Biochem 55 (2013), 39-50.
28. J. Tong, X. Yan, and L. Yu, The late stage of autophagy: Cellular events, and molecular regulation, Protein Cell 1 (2010), 907-915.
29. I. Tanida, N. Minematsu-Ikeguchi, T. Ueno, and E. Kominami, Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy, Autophagy 1 (2005), 84-91.
30. K. Sun, W. Deng, S. Zhang, N. Cai, S. Jiao, J. Song, and L. Wei, Paradoxical roles of autophagy in different stages of tumorigenesis: Protector for normal or cancer cells. Cell Biosci 3 (2013), 35.
31. W. Liao, L. Sun, C. Wang, H. Huang, J. Liu, W. Liao, and M. Shi, LC3A-positive stone-like" structures predict an adverse prognosis of gastric cancer, Anat Rec (Hoboken) 297 (2014), 653-662.
32. G.F. Guo, W.Q. Jiang, B. Zhang, Y.C. Cai, R.H. Xu, X.X. Chen, F. Wang, and L.P. Xia, Autophagy-related proteins Beclin-1, and LC3 predict cetuximab efficacy in advanced colorectal cancer. World J Gastroenterol 17 (2011), 4779-4786.
33. A. Giatromanolaki, M.I. Koukourakis, A.L. Harris, A. Polychronidis, K.C. Gatter, and E. Sivridis, Prognostic relevance of light chain 3 (LC3A) autophagy patterns in colorectal adenocarcinomas. J Clin Pathol 63 (2010), 867-872.
34. Z. Yang, R.A. Ghoorun, X. Fan, P.Wu, Y. Bai, J. Li, H. Chen, L. Wang, and J. Wang, High expression of Beclin-1 predicts favorable prognosis for patients with colorectal cancer. Clin Res Hepatol Gastroenterol 39 (2015), 98-106.
35. M.R. Kang, M.S. Kim, J.E. Oh, Y.R. Kim, S.Y. Song, S.S. Kim, C.H. Ahn, N.J. Yoo, and S.H. Lee, Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B, and ATG12 in gastric, and colorectal cancers with microsatellite instability. J Pathol 217 (2009), 702-706.
36. J. Ge, Z. Chen, J. Huang, J. Chen, W. Yuan, Z. Deng, and Z. Chen, Upregulation of autophagy-related gene-5 (ATG-5) is associated with chemoresistance in human gastric cancer. PLoS ONE 9 (2014), e110293.
37. L. Wang, Y. Wang, Y. Lu, Q. Zhang, and X. Qu, Heterozygous deletion of ATG5 in Apc (Min/+) mice promotes intestinal adenoma growth, and enhances the anti-Tumor efficacy of interferon-gamma. Cancer Biol Ther 16 (2015), 383-391.
38. J. Levy, W. Cacheux, M.A. Bara, A. L?Hermitte, P. Lepage, M. Fraudeau, C. Trentesaux, J. Lemarchand, A. Durand, A.M. Crain, C. Marchiol, G. Renault, F. Dumont, F. Letourneur, M. Delacre, A. Schmitt, B. Terris, C. Perret, M. Chamaillard, J.P. Couty, and B. Romagnolo, Intestinal inhibition of Atg7 prevents tumour initiation through a microbiome-influenced immune response, and suppresses tumour growth. Nat Cell Biol 17 (2015), 1062-1073.
39. H. Cheong, Integrating autophagy, and metabolism in cancer. Arch Pharm Res 38 (2015), 358-371.
40. J.Y. Guo, B. Xia, and E. White, Autophagy-mediated tumor promotion. Cell 155 (2013), 1216-1219.
41. B.J. Altman, and J.C. Rathmell, Metabolic stress in au tophagy, and cell death pathways, Cold Spring Harb Perspect Biol 4 (2012), a008763.
42. R. Mathew, S. Kongara, B. Beaudoin, C.M. Karp, K. Bray, K. Degenhardt, G. Chen, S. Jin, and E. White, Autophagy suppresses tumor progression by limiting chromosomal instability, Genes Dev 21 (2007), 1367-1381.
43. R. Mathew, C.M. Karp, B. Beaudoin, N. Vuong, G. Chen, H.Y. Chen, K. Bray, A. Reddy, G. Bhanot, C. Gelinas, R.S. Dipaola, V. Karantza-Wadsworth, and E. White, Autophagy suppresses tumorigenesis through elimination of p62. Cell 137 (2009), 1062-1075.
44. F. Ren, G. Shu, G. Liu, D. Liu, J. Zhou, L. Yuan, and J. Zhou, Knockdown of p62/sequestosome 1 attenuates autophagy, and inhibits colorectal cancer cell growth. Mol Cell Biochem 385 (2014), 95-102.
45. G.L. Bellot, D. Liu, and S. Pervaiz, ROS, autophagy, mitochondria, and cancer: Ras, the hidden master? Mitochondrion 13 (2013), 155-162.
46. Q. Huang, Y.T. Wu, H.L. Tan, C.N. Ong, and H.M. Shen, A novel function of poly (ADP-ribose) polymerase-1 in modulation of autophagy, and necrosis under oxidative stress. Cell Death Differ 16 (2009), 264-277.
47. M. Djavaheri-Mergny, M. Amelotti, J. Mathieu, F. Besancon, C. Bauvy, S. Souquere, G. Pierron, and P. Codogno, NF-kappaB activation represses tumor necrosis factor-Alphainduced autophagy, J Biol Chem 281 (2006), 30373-30382.
48. Y. Ci, K. Shi, J. An, Y. Yang, K. Hui, P.Wu, L. Shi, and C. Xu, ROS inhibit autophagy by downregulating ULK1 mediated by the phosphorylation of p53 in selenite-Treated NB4 cells. Cell Death Dis 5 (2014), e1542.
49. J. Wen, Y. Zhao, and L. Guo, Orexin A induces autophagy in HCT-116 human colon cancer cells through the ERK signaling pathway. Int J Mol Med (2015
50. C. Wang, C.C. Liang, Z.C. Bian, Y. Zhu, and J.L. Guan, FIP200 is required for maintenance, and differentiation of postnatal neural stem cells. Nat Neurosci 16 (2013), 532-542.
51. M. Mortensen, E.J. Soilleux, G. Djordjevic, R. Tripp, M. Lutteropp, E. Sadighi-Akha, A.J. Stranks, J. Glanville, S. Knight, S.E. Jacobsen, K.R. Kranc, and A.K. Simon, The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance, J ExpMed 208 (2011), 455-467.
52. X.H. Liang, S. Jackson, M. Seaman, K. Brown, B. Kempkes, H. Hibshoosh, and B. Levine, Induction of autophagy, and inhibition of tumorigenesis by beclin 1. Nature 402 (1999), 672-676.
53. J.H. Choi, Y.S. Cho, Y.H. Ko, S.U. Hong, J.H. Park andM.A. Lee, Absence of autophagy-related proteins expression is associated with poor prognosis in patients with colorectal adenocarcinoma, Gastroenterol Res Pract 2014 (2014), 179586.
54. M.Y. Zhang, W.F. Gou, S. Zhao, X.Y. Mao, Z.H. Zheng, Y. Takano, and H.C. Zheng, Beclin 1 expression is closely linked to colorectal carcinogenesis, and distant metastasis of colorectal carcinoma. Int J Mol Sci 15 (2014), 14372-14385.
55. Z. Yue, S. Jin, C. Yang, A.J. Levine, and N. Heintz, Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A 100 (2003), 15077-15082.
56. M.S. Kim, E.G. Jeong, C.H. Ahn, S.S. Kim, S.H. Lee, and N.J. Yoo, Frameshift mutation of UVRAG, an autophagyrelated gene, in gastric carcinomas with microsatellite instability, Hum Pathol 39 (2008), 1059-1063.
57. C. Liang, P. Feng, B. Ku, I. Dotan, D. Canaani, B.H. Oh, and J.U. Jung, Autophagic, and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat Cell Biol 8 (2006), 688-699.
58. L.L. Fu, Y. Cheng, and B. Liu, Beclin-1: Autophagic regulator, and therapeutic target in cancer. Int J Biochem Cell Biol 45 (2013), 921-924.
59. S. He, and C. Liang, Frameshift mutation of UVRAG: Switching a tumor suppressor to an oncogene in colorectal cancer, Autophagy 11 (2015), 1939-1940.
60. Y. Zhao, J. Yang, W. Liao, X. Liu, H. Zhang, S. Wang, D. Wang, J. Feng, L. Yu, and W.G. Zhu, Cytosolic FoxO1 is essential for the induction of autophagy, and tumour suppressor activity. Nat Cell Biol 12 (2010), 665-675.
61. J.Y. Guo, H.Y. Chen, R. Mathew, J. Fan, A.M. Strohecker, G. Karsli-Uzunbas, J.J. Kamphorst, G. Chen, J.M. Lemons, V. Karantza, H.A. Coller, R.S. Dipaola, C. Gelinas, J.D. Rabinowitz, and E. White, Activated Ras requires autophagy to maintain oxidative metabolism, and tumorigenesis, Genes Dev 25 (2011), 460-470.
62. G.N. Naumov, J. Folkman, and O. Straume, Tumor dormancy due to failure of angiogenesis: Role of the microenvironment. Clin Exp Metastasis 26 (2009), 51-60.
63. A.M. Choi, S.W. Ryter, and B. Levine, Autophagy in human health, and disease. N Engl J Med 368 (2013), 651-662.
64. Y.K. Jo, S.C. Kim, I.J. Park, S.J. Park, D.H. Jin, S.W. Hong, D.H. Cho, and J.C. Kim, Increased expression of ATG10 in colorectal cancer is associated with lymphovascular invasion, and lymph node metastasis. PLoS ONE 7 (2012), e52705.
65. S. Alves, L. Castro, M.S. Fernandes, R. Francisco, P. Castro, M. Priault, S.R. Chaves, M.P. Moyer, C. Oliveira, R. Seruca, M. Corte-Real, M.J. Sousa, and A. Preto, Colorectal cancerrelated mutant KRAS alleles function as positive regulators of autophagy, Oncotarget 6 (2015), 30787-30802.
66. X. Jiang, M. Overholtzer, and C.B. Thompson, Autophagy in cellular metabolism, and cancer. J Clin Invest 125 (2015), 47-54.
67. J. Li, N. Hou, A. Faried, S. Tsutsumi, and H. Kuwano, Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro, and in vivo model. Eur J Cancer 46 (2010), 1900-1909.
68. W.K.Wu, S.B. Coffelt, C.H. Cho, X.J. Wang, C.W. Lee, F.K. Chan, J. Yu, and J.J. Sung, The autophagic paradox in cancer therapy. Oncogene 31 (2012), 939-953.
69. X. Sui, L. Jin, X. Huang, S. Geng, C. He, and X. Hu, p53 signaling, and autophagy in cancer: A revolutionary strategy could be developed for cancer treatment, Autophagy 7 (2011), 565-571.
70. W.T. Bellamy, Prediction of response to drug therapy of cancer. A review of in vitro assays, Drugs 44 (1992), 690-708.
71. Z. Feng, H. Zhang, A.J. Levine, and S. Jin, The coordinate regulation of the p53, and mTOR pathways in cells. Proc Natl Acad Sci U S A 102 (2005), 8204-8209.
72. S. Jin, p53, Autophagy, and tumor suppression, Autophagy 1 (2005), 171-173.
73. E. Tasdemir, M.C. Maiuri, L. Galluzzi, I. Vitale, M. Djavaheri-Mergny, M. D?Amelio, A. Criollo, E. Morselli, C. Zhu, F. Harper, U. Nannmark, C. Samara, P. Pinton, J.M. Vicencio, R. Carnuccio, U.M. Moll, F. Madeo, P. Paterlini-Brechot, R. Rizzuto, G. Szabadkai, G. Pierron, K. Blomgren, N. Tavernarakis, P. Codogno, F. Cecconi, and G. Kroemer, Regulation of autophagy by cytoplasmic p53. Nat Cell Biol 10 (2008), 676-687.
74. D. Papadatos-Pastos, R. Rabbie, P. Ross, and D. Sarker, The role of the PI3K pathway in colorectal cancer. Crit Rev Oncol Hematol 94 (2015), 18-30.
75. C. Porta, C. Paglino, and A. Mosca, Targeting PI3K/Akt/ mTOR Signaling in Cancer, Front Oncol 4 (2014), 64.
76. B. Karakas, K.E. Bachman, and B.H. Park, Mutation of the PIK3CA oncogene in human cancers. Br J Cancer 94 (2006), 455-459.
77. S. Lorin, A. Hamai, M. Mehrpour, and P. Codogno, Autophagy regulation, and its role in cancer, Semin Cancer Biol 23 (2013), 361-379.
78. E.A. Dunlop, D.K. Hunt, H.A. Acosta-Jaquez, D.C. Fingar, and A.R. Tee, ULK1 inhibits mTORC1 signaling, promotes multisite Raptor phosphorylation, and hinders substrate binding, Autophagy 7 (2011), 737-747.
79. H.K. Roy, B.F. Olusola, D.L. Clemens, W.J. Karolski, A. Ratashak, H.T. Lynch, and T.C. Smyrk, AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis, Carcinogenesis 23 (2002), 201-205.
80. K. Nosho, T. Kawasaki, M. Ohnishi, Y. Suemoto, G.J. Kirkner, D. Zepf, L. Yan, J.A. Longtine, C.S. Fuchs, and S. Ogino, PIK3CA mutation in colorectal cancer: Relationship with genetic, and epigenetic alterations. Neoplasia 10 (2008), 534-541.
81. M. Miyaki, T. Iijima, T. Yamaguchi, K. Takahashi, H. Matsumoto, M. Yasutome, N. Funata, and T. Mori, Mutations of the PIK3CA gene in hereditary colorectal cancers. Int J Cancer 121 (2007), 1627-1630.
82. I. Pal, S. Parida, B.N. Prashanth Kumar, P. Banik, K. Kumar Dey, S. Chakraborty, S.K. Bhutia, and M. Mandal, Blockade of autophagy enhances proapoptotic potential of BI-69A11, a novel Akt inhibitor, in colon carcinoma. Eur J Pharmacol 765 (2015), 217-227.
83. J. Ying, Q. Xu, B. Liu, G. Zhang, L. Chen, and H. Pan, The expression of the PI3K/AKT/mTOR pathway in gastric cancer, and its role in gastric cancer prognosis. Onco Targets Ther 8 (2015), 2427-2433.
84. B.S. Zhu, J.L. Sun, W. Gong, X.D. Zhang, Y.Y. Wu, and C.G. Xing, Effects of 5fluorouracil, and class III phosphoinositide 3kinase small interfering RNA combination therapy on SGC7901 human gastric cancer cells. Mol Med Rep 11 (2015), 1891-1898.
85. J. Downward, Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 3 (2003), 11-22.
86. N. Charette, C. Vandeputte, and P. Starkel, Ras in digestive oncology: From molecular biology to clinical implications. Curr Opin Oncol 26 (2014), 454-461.
87. E. Schmukler, Y. Kloog, and R. Pinkas-Kramarski, Ras, and autophagy in cancer development, and therapy, Oncotarget 5 (2014), 577-586.
88. N. Knijn, L.J. Mekenkamp, M. Klomp, M.E. Vink-Borger, J. Tol, S. Teerenstra, J.W. Meijer, M. Tebar, S. Riemersma, J.H. van Krieken, C.J. Punt, and I.D. Nagtegaal, KRAS mutation analysis: A comparison between primary tumours, and matched liver metastases in 305 colorectal cancer patients. Br J Cancer 104 (2011), 1020-1026.
89. E. Swiderek, W. Kalas, E. Wysokinska, A. Pawlak, J. Rak, and L. Strzadala, The interplay between epigenetic silencing, oncogenic KRas, and HIF-1 regulatory pathways in control of BNIP3 expression in human colorectal cancer cells, Biochem Biophys Res Commun 441 (2013), 707-712.
90. S. Pattingre, C. Bauvy, and P. Codogno, Amino acids interfere with the ERK1/2-dependent control of macroautophagy by controlling the activation of Raf-1 in human colon cancer HT-29 cells, J Biol Chem 278 (2003), 16667-16674.
91. N.C. van Grieken, T. Aoyama, P.A. Chambers, D. Bottomley, L.C. Ward, I. Inam, T.E. Buffart, K. Das, T. Lim, B. Pang, S.L. Zhang, I.B. Tan, B. Carvalho, D.A. Heideman, Y. Miyagi, Y. Kameda, T. Arai, G.A. Meijer, A. Tsuburaya, P. Tan, T. Yoshikawa, and H.I. Grabsch, KRAS, and BRAF mutations are rare, and related to DNA mismatch repair deficiency in gastric cancer from the East, and the West: Results from a large international multicentre study. Br J Cancer 108 (2013), 1495-1501.
92. C. Clancy, M.R. Joyce andM.J. Kerin, The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer. Cancer Biomark 15 (2015), 103-113.
93. L.L. Fu, X. Wen, J.K. Bao, and B. Liu, MicroRNAmodulated autophagic signaling networks in cancer. Int J Biochem Cell Biol 44 (2012), 733-736.
94. J. Kubisch, D. Turei, L. Foldvari-Nagy, Z.A. Dunai, L. Zsakai, M. Varga, T. Vellai, P. Csermely, and T. Korcsmaros, Complex regulation of autophagy in cancer -integrated approaches to discover the networks that hold a double-edged sword, Semin Cancer Biol 23 (2013), 252-261.
95. J. Zhao, Y. Nie, H. Wang, and Y. Lin, miR-181a suppresses autophagy, and sensitizes gastric cancer cells to cisplatin, Gene (2015
96. Y. An, Z. Zhang, Y. Shang, X. Jiang, J. Dong, P. Yu, Y. Nie, and Q. Zhao, miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12, and HMGB2. Cell Death Dis 6 (2015), e1766.
97. A.T. Sumbul, B. Gogebakan, S. Ergun, E. Yengil, C.Y. Batmaci, O. Tonyali, and M. Yaldiz, miR-204-5p expression in colorectal cancer: An autophagy-Associated gene. Tumour Biol 35 (2014), 12713-12719.
98. N. Hou, J. Han, J. Li, Y. Liu, Y. Qin, L. Ni, T. Song, and C. Huang, MicroRNA profiling in human colon cancer cells during 5-fluorouracil-induced autophagy. PLoS ONE 9 (2014), e114779.
99. K. Zhao, B.S. Zhu, W. Gong, M.L. Zhu, Z.T. Gao, Y.Y. Wu, Q. Chen, X.D. Yang, and C.G. Xing, SN50 enhances the effects of LY294002 on cell death induction in gastric cancer cell line SGC7901. Arch Med Sci 9 (2013), 990-998.
100. L.X. Rui, S.Y. Shu, W.J. Jun, C.Z. Mo, S.Z. Wu, L.S. Min, L. Yuan, P.J. Yong, S.Z. Cheng, W.S. Sheng, and T.Z. Yao, The dual induction of apoptosis, and autophagy by SZC014, a synthetic oleanolic acid derivative, in gastric cancer cells via NF-kappaB pathway. Tumour Biol (2015
101. M. Liu, C.M. Li, Z.F. Chen, R. Ji, Q.H. Guo, Q. Li, H.L. Zhang, and Y.N. Zhou, Celecoxib regulates apoptosis, and autophagy via the PI3K/Akt signaling pathway in SGC-7901 gastric cancer cells, Int JMol Med 33 (2014), 1451-1458.
102. S. Huang, and F.A. Sinicrope, Celecoxib-induced apoptosis is enhanced by ABT-737, and by inhibition of autophagy in human colorectal cancer cells, Autophagy 6 (2010), 256-269.
103. F.V. Din, A. Valanciute, V.P. Houde, D. Zibrova, K.A. Green, K. Sakamoto, D.R. Alessi, and M.G. Dunlop, Aspirin inhibits mTOR signaling, activates AMP-Activated protein kinase, and induces autophagy in colorectal cancer cells, Gastroenterology 142 (2012), 1504-1515 e3.
104. J.C. Wu, F.Z. Wang, M.L. Tsai, C.Y. Lo, V. Badmaev, C.T. Ho, Y.J. Wang, and M.H. Pan, Se-Allylselenocysteine induces autophagy by modulating the AMPK/mTOR signaling pathway, and epigenetic regulation of PCDH17 in human colorectal adenocarcinoma cells. Mol Nutr Food Res (2015
105. L. Hou, Y. Li, H. Song, Z. Zhang, Y. Sun, X. Zhang, and K. Wu, Protective macroautophagy is involved in vitamin e succinate effects on human gastric carcinoma cell line SGC-7901 by inhibiting mTOR axis phosphorylation. PLoS ONE 10 (2015), e0132829.